Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia

Recruiting now

Conditions studied: Cervical Intraepithelial Neoplasia

In brief

HPV vaccination has emerged as a strategy to reduce the risk of recurrence oafter excisional treatment. However, only few data are aviable. In this trial the investigators aim to assess the role of HPV vaccination in women traeted for HPV-related lesions

Key facts

Study ID

NCT06611020

Run by

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

People needed

600

Starts

2020-01-01

Expected to finish

2027-01-31

Last updated by the study team

2024-09-26

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Treatment of HPV-related disease

You may not qualify if…

• Previous HPV vaccination

Where it is running

• Fondazione IRCCS Istituto Nazionale dei Tumori — Milan, Lombardy, Italy (enrolling)
• Fondazione IRCCS Istituto Nazionale dei Tumori — Milan, Lombardy, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.